PMID 20143256 Pfizer/Hospira
Common GI side effects (affecting more than 1 in 10 people) according to the SmPC: Nausea : The most frequent side effect, reported in approximately 44% of patients in clinical trials, usually most pronounced during the first few weeks and with dose increases Diarrhoea : Affects roughly 30% of users, typically mild to moderate and transient Vomiting : Occurs in about 24% of patients, often associated with eating too quickly or consuming large portions Constipation : Reported in approximately 24% of users, which may require dietary modification or occasional laxative use Abdominal pain or discomfort : Affects around 20% of patients, usually described as cramping or bloating Dyspepsia and reflux : Indigestion and heartburn occur in approximately 9% of users Less common but significant GI effects : Delayed gastric emptying : Whilst this is the intended pharmacological effect, in some cases it can cause persistent nausea, vomiting, and inability to tolerate food Pancreatitis : Has been reported in clinical trials and post-marketing
Gentle swirling or patient waiting is always the correct approach
How to reconstitute a 5mg BPC-157 vial Reconstitution means mixing the powder with bacteriostatic water to create an injectable solution
(1) Water helps prevent dehydration, which can cloud thinking and contribute to constipation
Urban areas with academic medical centers may have longer waits, while private practice endocrinologists in suburban areas often offer more rapid access
